跳至主要内容
临床试验/NCT00918710
NCT00918710Unknown不适用

Impact of the Human Papillomavirus (HPV) Status in Carcinologic Prognosis of Oropharynx Squamous Cell Carcinoma.

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 362 人开始时间: 2009年5月最近更新:
适应症

试验速览

阶段
不适用
入组人数
362
试验地点
1
主要终点
DFS at 2 years in HPV + and - tumors

研究概览

简要总结

High risk papillomavirus (HR-HPV) have an oncogenic role in Oropharyngeal squamous cell carcinomas (OP-SCC) in at least 25% of the cases and the prevalence is increasing. HPV+ might be more chemo and radio sensible with a better prognosis (disease-free survival (DFS) and overall survival (OS) as compared to HPV negative OP-SCC ; hypothesis : 2y DFS > 20% improvement). The principal objective is to determine the impact of the status of HR-HPV in the prognosis of the OP-SCC. The principal criteria is the 2-years DFS.

Secondary objective : virologic characteristics of HPV+ tumors.

详细描述

The study has no impact on the treatment of the observed population. The clinical study include TNM status, previous story of HPV infection, smoking and alcoholic habits, treatment and outcome during 5 years. The virologic study include : HPV type, E6-E7 viral charge of HPV16, viral DNA integration in the tumoral genome, HPV16 variants, expression of HPV 16, 18, 31, 45 coding oncoproteins E6-E7 mRNA. Moreover a serologic study will be done.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Squamous cell carcinoma of Oropharynx proven histologically
  • All stages TNM
  • informed consent
  • No previous or simultaneous Head Neck cancer

排除标准

  • Squamous cell carcinoma other than oropharynx
  • 2nd synchronous SCC localization
  • No consent
  • age < 18

结局指标

主要结局

DFS at 2 years in HPV + and - tumors

时间窗: at 2 years

次要结局

  • HPV status(At the inclusion)
  • Overall survival(At 5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Human Papillomavirus and Oropharynx Carcinoma | 临床试验